HEART Stock Overview
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Scandinavian Real Heart AB (Publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.81 |
| 52 Week High | kr2.80 |
| 52 Week Low | kr0.36 |
| Beta | 0.079 |
| 1 Month Change | 33.55% |
| 3 Month Change | 30.97% |
| 1 Year Change | -66.72% |
| 3 Year Change | -88.78% |
| 5 Year Change | -94.07% |
| Change since IPO | -79.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEART | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -3.1% | 1.9% | 0.6% |
| 1Y | -66.7% | -6.0% | 11.1% |
Return vs Industry: HEART underperformed the Swedish Medical Equipment industry which returned -5.4% over the past year.
Return vs Market: HEART underperformed the Swedish Market which returned 11.2% over the past year.
Price Volatility
| HEART volatility | |
|---|---|
| HEART Average Weekly Movement | 8.0% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.6% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: HEART's share price has been volatile over the past 3 months.
Volatility Over Time: HEART's weekly volatility has decreased from 14% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 15 | Ina Perkins | realheart.se |
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products.
Scandinavian Real Heart AB (Publ) Fundamentals Summary
| HEART fundamental statistics | |
|---|---|
| Market cap | kr78.76m |
| Earnings (TTM) | -kr67.98m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.2x
P/E RatioIs HEART overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEART income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | -kr14.15m |
| Gross Profit | kr14.15m |
| Other Expenses | kr82.13m |
| Earnings | -kr67.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 11, 2024
| Earnings per share (EPS) | -0.70 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 10.1% |
How did HEART perform over the long term?
See historical performance and comparison